Literature DB >> 22042240

Evaluation of nodal response after intra-arterial chemoradiation for node-positive head and neck cancer.

Tomohiro Sakashita1, Akihiro Homma, Nobuhiko Oridate, Hiromitsu Hatakeyama, Satoshi Kano, Takatsugu Mizumachi, Satoshi Fukuda.   

Abstract

This retrospective study aimed to compare the accuracy of two nodal evaluation criteria using computed tomography after intra-arterial chemoradiation in node-positive head and neck squamous cell carcinomas. Computed tomography was used to evaluate radiographic nodal response 4-8 weeks after intra-arterial chemoradiation. We compared the accuracy of two different criteria: criterion 1 (radiographic complete response was recorded in the absence of focal abnormalities and if the maximum diameter of the metastatic node was less than 15 mm), and criterion 2 (radiographic complete response was recorded in the absence of focal abnormalities and if the minimum diameter of metastatic nodes was less than 7 mm in level II and if the minimum diameter of metastatic nodes in the rest of the neck was less than 6 mm). Positive predictive values were criterion 1: 69.2%, criterion 2: 47.8%; negative predictive values were criterion 1: 88.5%, criterion 2: 90.5%. Positive likelihood ratios were criterion 1: 7.50, criterion 2: 3.06. The difference between each criteria was statistically significant using McNemar's test (p = 0.0016). Computed tomography evaluation accuracy of nodal response after intra-arterial chemoradiation was comparable to recent reports, and it was feasible to perform salvage neck dissection by computed tomography evaluation for nodal response. We recommend using criterion 1 because of its simplicity and reliability.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22042240     DOI: 10.1007/s00405-011-1814-5

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  15 in total

1.  Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer.

Authors:  J P Pignon; J Bourhis; C Domenge; L Designé
Journal:  Lancet       Date:  2000-03-18       Impact factor: 79.321

2.  Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: a randomized multicenter study.

Authors:  T G Wendt; G G Grabenbauer; C M Rödel; H J Thiel; H Aydin; R Rohloff; T P Wustrow; H Iro; C Popella; A Schalhorn
Journal:  J Clin Oncol       Date:  1998-04       Impact factor: 44.544

3.  Efficacy of targeted supradose cisplatin and concomitant radiation therapy for advanced head and neck cancer: the Memphis experience.

Authors:  K T Robbins; P Kumar; W F Regine; F S Wong; A B Weir; P Flick; L E Kun; R Palmer; T Murry; J Fontanesi; R Ferguson; R Thomas; W Hartsell; C U Paig; G Salazar; L Norfleet; C B Hanchett; V Harrington; H B Niell
Journal:  Int J Radiat Oncol Biol Phys       Date:  1997-05-01       Impact factor: 7.038

4.  Value of FDG PET in assessment of treatment response and surveillance in head-and-neck cancer patients after intensity modulated radiation treatment: a preliminary report.

Authors:  Min Yao; Michael M Graham; Russell B Smith; Kenneth J Dornfeld; Mark Skwarchuk; Henry T Hoffman; Gerry F Funk; Scott M Graham; Yusuf Menda; John M Buatti
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-12-01       Impact factor: 7.038

Review 5.  The size of lymph nodes in the neck on sonograms as a radiologic criterion for metastasis: how reliable is it?

Authors:  M W van den Brekel; J A Castelijns; G B Snow
Journal:  AJNR Am J Neuroradiol       Date:  1998-04       Impact factor: 3.825

6.  Diagnosis of lymph node metastases of head and neck cancer and evaluation of effects of chemoradiotherapy using ultrasonography.

Authors:  Madoka K Furukawa; Masaki Furukawa
Journal:  Int J Clin Oncol       Date:  2010-01-29       Impact factor: 3.402

7.  Utility of positron emission tomography for the detection of disease in residual neck nodes after (chemo)radiotherapy in head and neck cancer.

Authors:  Sandro V Porceddu; Elizabeth Jarmolowski; Rodney J Hicks; Rob Ware; LeAnn Weih; Danny Rischin; June Corry; Lester J Peters
Journal:  Head Neck       Date:  2005-03       Impact factor: 3.147

Review 8.  Planned neck dissection for patients with complete response to chemoradiotherapy: a concept approaching obsolescence.

Authors:  Alfio Ferlito; June Corry; Carl E Silver; Ashok R Shaha; K Thomas Robbins; Alessandra Rinaldo
Journal:  Head Neck       Date:  2010-02       Impact factor: 3.147

9.  Superselective high-dose cisplatin infusion with concomitant radiotherapy in patients with advanced cancer of the nasal cavity and paranasal sinuses: a single institution experience.

Authors:  Akihiro Homma; Nobuhiko Oridate; Fumiyuki Suzuki; Shigenari Taki; Takeshi Asano; Daisuke Yoshida; Rikiya Onimaru; Takeshi Nishioka; Hiroki Shirato; Satoshi Fukuda
Journal:  Cancer       Date:  2009-10-15       Impact factor: 6.860

10.  Early prediction of response to chemoradiotherapy for head and neck cancer: reliability of restaging with combined positron emission tomography and computed tomography.

Authors:  James P Malone; Michael A T Gerberi; Syam Vasireddy; Larry F Hughes; Krishna Rao; Bruce Shevlin; Matthew Kuhn; Dean Collette; Joel Tennenhouse; K Thomas Robbins
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2009-11
View more
  1 in total

1.  CT-based follow-up following radiotherapy or radiochemotherapy for locally advanced head and neck cancer; outcome and development of a prognostic model for regional control.

Authors:  Daan Nevens; Olivier Vantomme; Annouschka Laenen; Robert Hermans; Sandra Nuyts
Journal:  Br J Radiol       Date:  2016-10-06       Impact factor: 3.039

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.